NCT05963282View on ClinicalTrials.gov

Comparative Effectiveness of Entresto (Sacubitril/Valsartan) Versus ACEi/ARB in de Novo Heart Failure Patients

CompletedOBSERVATIONAL
Enrollment

9,870

Participants

Timeline

Start Date

November 29, 2021

Primary Completion Date

July 19, 2022

Study Completion Date

July 19, 2022

Conditions
de Novo Heart Failure
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY